HAVCR1 and acute kidney injury: Increasingly, NBMs such as kidney injury molecule-1 (KIM-1), NGAL, and CYSC, as well as metabolomic or proteomic profiles, are being utilized in drug development and clinical practice to detect AKI earlier and have greater sensitivity than conventional clinical measures of kidney function.6